SCHEMBL1012599

SCHEMBL1012599

COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)c2cc1OCCN1CCSC(=O)C1=O

nearest known ligand 0.76

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BRAF P15056 19/20 0.76
RAF1 P04049 17/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1012725 0.97 BRAF (0.76) BRAFRAF1
SCHEMBL1012919 0.97 BRAF (0.76) BRAFRAF1
SCHEMBL1015120 0.87 BRAF (0.76) BRAFRAF1
SCHEMBL17911693 0.87 BRAF (0.89) BRAFRAF1
SCHEMBL1012150 0.86 BRAF (1.00) BRAFRAF1
SCHEMBL1011171 0.86 BRAF (1.00) BRAFRAF1
SCHEMBL1013669 0.86 BRAF (1.00) BRAFRAF1
SCHEMBL1013266 0.86 BRAF (1.00) BRAFRAF1
SCHEMBL1012532 0.86 BRAF (1.00) BRAFRAF1
SCHEMBL1014341 0.86 BRAF (1.00) BRAFRAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268623-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2011-01-05 EP disclosed
WO-2009117080-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATON (US) 2009-09-24 WO disclosed